187 related articles for article (PubMed ID: 7560087)
21. New form of X-linked dominant hereditary nephritis in dogs.
Lees GE; Helman RG; Kashtan CE; Michael AF; Homco LD; Millichamp NJ; Camacho ZT; Templeton JW; Ninomiya Y; Sado Y; Naito I; Kim Y
Am J Vet Res; 1999 Mar; 60(3):373-83. PubMed ID: 10188823
[TBL] [Abstract][Full Text] [Related]
22. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.
Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M
J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760
[TBL] [Abstract][Full Text] [Related]
23. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
25. [Alport's syndrome: apropos of 2 families].
Grünfeld JP
Nephrologie; 2000; 21(6):295-8. PubMed ID: 11117109
[TBL] [Abstract][Full Text] [Related]
26. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth.
Thielen BK; Barker DF; Nelson RD; Zhou J; Kren SM; Segal Y
Hum Mutat; 2003 Nov; 22(5):419. PubMed ID: 14517961
[TBL] [Abstract][Full Text] [Related]
27. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
28. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
29. Distribution of a1(IV) and a3(IV) chains of type IV collagen in lung tumours.
Polette M; Thiblet J; Ploton D; Buisson AC; Monboisse JC; Tournier JM; Birembaut P
J Pathol; 1997 Jun; 182(2):185-91. PubMed ID: 9274529
[TBL] [Abstract][Full Text] [Related]
30. Absence of alpha 6(IV) collagen in kidney and skin of X-linked Alport syndrome patients.
Hino S; Takemura T; Sado Y; Kagawa M; Oohashi T; Ninomiya Y; Yoshioka K
Pediatr Nephrol; 1996 Dec; 10(6):742-4. PubMed ID: 8971895
[TBL] [Abstract][Full Text] [Related]
31. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Japanese Alport Network.
Naito I; Kawai S; Nomura S; Sado Y; Osawa G
Kidney Int; 1996 Jul; 50(1):304-11. PubMed ID: 8807602
[TBL] [Abstract][Full Text] [Related]
32. Distribution of collagen IV in human ocular tissues.
Ishizaki M; Westerhausen-Larson A; Kino J; Hayashi T; Kao WW
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2680-9. PubMed ID: 7688359
[TBL] [Abstract][Full Text] [Related]
33. X-linked Alport syndrome with normal distribution of collagen IV alpha chains in epidermal basement membrane.
Naito I; Nomura S; Inoue S; Kagawa M; Matsubara T; Araki T; Taki M; Ohmori H; Manabe K; Kawai S; Osawa G; Sado Y
Contrib Nephrol; 1997; 122():134-9. PubMed ID: 9399056
[No Abstract] [Full Text] [Related]
34. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.
Kalluri R; Shield CF; Todd P; Hudson BG; Neilson EG
J Clin Invest; 1997 May; 99(10):2470-8. PubMed ID: 9153291
[TBL] [Abstract][Full Text] [Related]
35. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution.
Gubler MC; Knebelmann B; Beziau A; Broyer M; Pirson Y; Haddoum F; Kleppel MM; Antignac C
Kidney Int; 1995 Apr; 47(4):1142-7. PubMed ID: 7783412
[TBL] [Abstract][Full Text] [Related]
36. Differential distribution of type IV collagen chains in the developing rat testis and ovary.
Fröjdman K; Pelliniemi LJ; Virtanen I
Differentiation; 1998 Jul; 63(3):125-30. PubMed ID: 9697306
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing in the alpha 5(IV) collagen gene in human kidney and skin tissues.
Saito A; Sakatsume M; Yamazaki H; Arakawa M
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):19-24. PubMed ID: 7509007
[TBL] [Abstract][Full Text] [Related]
38. Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome.
Naito I; Nomura S; Inoue S; Kagawa M; Kawai S; Gunshin Y; Joh K; Tsukidate C; Sado Y; Osawa G
J Clin Pathol; 1997 Nov; 50(11):919-22. PubMed ID: 9462240
[TBL] [Abstract][Full Text] [Related]
39. Expression of novel basement membrane components in the developing human kidney and eye.
Kleppel MM; Michael AF
Am J Anat; 1990 Feb; 187(2):165-74. PubMed ID: 2301276
[TBL] [Abstract][Full Text] [Related]
40. Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome.
Dehan P; Van den Heuvel LP; Smeets HJ; Tryggvason K; Foidart JM
Nephrol Dial Transplant; 1996 Oct; 11(10):1983-8. PubMed ID: 8918711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
